Download
1 / 8
0 likes | 5 Views
Global bi-specific mabs market size is expected to reach $16.9 Bn by 2028 at a rate of 13.3%, segmented as by type, catumaxomab (removab), blinatumomab, duligotumab, emicizumab, amivantamab, faricimab, teclistamab<br>
E N D
Bi-Specific MAbS Global Market Report 2024 Global Forecast 2024 – 2033 Market Size, Drivers, And Trends Top Market Research Firm 2023! We are honored to be listed as a top company at the forefront of research, by the Business Management Review
Bi-Specific MAbS Market Segments The Business Research Company segments the bi-specific mabs market report as: Catumaxomab (Removab), Blinatumomab, Duligotumab, Emicizumab, Amivantamab, Faricimab, Teclistamab By Type In Vivo, In Vitro By Product Type By Indication Cancer, Hemophilia A, Ophthalmic Hospitals, Research Institutes, Other End-Users By End Use
Market Statistics The global Bi-Specific MAbS market size grew from $8.81 billion in 2023 to $10.25 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%. The Bi-Specific MAbS market size is expected to grow to $16.9 billion in 2028 at a compound annual growth rate (CAGR) of 13.3%. $16.9 B $10.25 B $8.81 B Click Here To Get A Sample Report
Key Market Drivers And Trends • Drivers The increasing prevalence of cancer and other chronic diseases is projected to contribute to the growth of the bispecific monoclonal antibodies market over the forecast period. Trends Companies in the bi-specific MAbs market are increasingly investing in various strategic initiatives, such as collaborations and partnerships to expand the product portfolio and geographical presence of the company. • Region North America was the largest region in the Bi-Specific MAbS market in 2023. The regions covered in the Bi-Specific MAbS market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Top Eleven Players In The Market • Major players in the market are: • F. Hoffmann-La Roche AG • Amgen Inc. • Johnson & Johnson • Innovent Biologics • Sino Biological Inc. • Kyowa Kirin • Zai Lab • Alphamab Oncology • Celldex Therapeutics • Biocon • EpimAb Biotherapeutics Get More Information On The Market Report
7 Reasons Why TBRC Is The Solution You Need • Global Macroeconomic Impact: Assess global economic factors' influence on market growth. • Market Size Ratios: Explore market size, GDP proportions, and expenditure per capita. • Global Perspective: Reports cover 60 geographies for a comprehensive global understanding. • Localized Strategies: Create region-specific strategies aligning with market nuances. • Investment Insights: Identify growth segments through forecast data and market insights. • Competitor Benchmarking: Compare performance against key competitors. • Presentation Support: Reports offer reliable data for internal and external presentations.
Americas The Business Research Company, 1295 N Providence Rd, Media, PA 19063, USA ✆ +1 3156230293 Get In Touch Europe The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE ✆ +44 207 1930 708 How ever you want to grow and expand, The Business Research Company can help as we provide research consulting solutions for businesses, government agencies consultancies, and market research companies. Asia The Business Research Company, 1st Floor, Anshu Colors Building, Road Number 1, Park View Enclave, Jubilee Hills, Hyderabad (India), 500033 ✆ +91 8897263534 info@tbrc.info
